MRK logo

Merck & Co (MRK) CAPEX

annual CAPEX:

$3.37B-$491.00M(-12.71%)
December 1, 2024

Summary

  • As of today (April 12, 2025), MRK annual capital expenditures is $3.37 billion, with the most recent change of -$491.00 million (-12.71%) on December 1, 2024.
  • During the last 3 years, MRK annual CAPEX has fallen by -$1.08 billion (-24.19%).
  • MRK annual CAPEX is now -24.19% below its all-time high of $4.45 billion, reached on December 31, 2021.

Performance

MRK CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKcash flow metrics

quarterly CAPEX:

$937.00M+$154.00M(+19.67%)
December 1, 2024

Summary

  • As of today (April 12, 2025), MRK quarterly capital expenditures is $937.00 million, with the most recent change of +$154.00 million (+19.67%) on December 1, 2024.
  • Over the past year, MRK quarterly CAPEX has stayed the same.
  • MRK quarterly CAPEX is now -37.11% below its all-time high of $1.49 billion, reached on December 31, 2014.

Performance

MRK quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKcash flow metrics

TTM CAPEX:

$3.37B-$52.00M(-1.52%)
December 1, 2024

Summary

  • As of today (April 12, 2025), MRK TTM capital expenditures is $3.37 billion, with the most recent change of -$52.00 million (-1.52%) on December 1, 2024.
  • Over the past year, MRK TTM CAPEX has stayed the same.
  • MRK TTM CAPEX is now -31.80% below its all-time high of $4.94 billion, reached on June 30, 2021.

Performance

MRK TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKcash flow metrics

MRK CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-12.7%0.0%0.0%
3 y3 years-24.2%0.0%0.0%
5 y5 years+0.1%0.0%0.0%

MRK CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.2%at low-18.4%+19.7%-24.9%at low
5 y5-year-24.2%+0.1%-35.2%+65.3%-31.8%at low
alltimeall time-24.2%+678.8%-37.1%+778.2%-31.8%+3060.3%

Merck & Co CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$3.37B(-12.7%)
$937.00M(+19.7%)
$3.37B(-1.5%)
Sep 2024
-
$783.00M(-1.0%)
$3.42B(-3.4%)
Jun 2024
-
$791.00M(-8.1%)
$3.54B(-4.7%)
Mar 2024
-
$861.00M(-12.9%)
$3.72B(-3.8%)
Dec 2023
$3.86B(-12.0%)
$989.00M(+9.6%)
$3.86B(-4.0%)
Sep 2023
-
$902.00M(-6.5%)
$4.02B(-5.3%)
Jun 2023
-
$965.00M(-4.2%)
$4.25B(-3.7%)
Mar 2023
-
$1.01B(-12.4%)
$4.41B(+0.5%)
Dec 2022
$4.39B(-1.3%)
$1.15B(+2.0%)
$4.39B(-1.3%)
Sep 2022
-
$1.13B(-0.3%)
$4.45B(-1.0%)
Jun 2022
-
$1.13B(+14.7%)
$4.49B(+3.3%)
Mar 2022
-
$984.00M(-18.5%)
$4.35B(-2.2%)
Dec 2021
$4.45B(+0.4%)
$1.21B(+3.1%)
$4.45B(-4.8%)
Sep 2021
-
$1.17B(+18.9%)
$4.67B(-5.5%)
Jun 2021
-
$986.00M(-8.9%)
$4.94B(+9.3%)
Mar 2021
-
$1.08B(-24.4%)
$4.53B(+2.2%)
Dec 2020
$4.43B(+31.5%)
$1.43B(-1.0%)
$4.43B(+9.9%)
Sep 2020
-
$1.45B(+154.9%)
$4.03B(+13.7%)
Jun 2020
-
$567.00M(-42.5%)
$3.54B(-5.7%)
Mar 2020
-
$986.00M(-4.5%)
$3.76B(+11.6%)
Dec 2019
$3.37B(+28.8%)
$1.03B(+7.7%)
$3.37B(+3.2%)
Sep 2019
-
$959.00M(+22.6%)
$3.27B(+10.3%)
Jun 2019
-
$782.00M(+31.4%)
$2.96B(+7.2%)
Mar 2019
-
$595.00M(-36.0%)
$2.76B(+5.5%)
Dec 2018
$2.62B(+38.5%)
$929.00M(+42.3%)
$2.62B(+8.9%)
Sep 2018
-
$653.00M(+12.0%)
$2.40B(+9.7%)
Jun 2018
-
$583.00M(+29.6%)
$2.19B(+9.5%)
Mar 2018
-
$450.00M(-37.1%)
$2.00B(+5.9%)
Dec 2017
$1.89B(+17.0%)
$715.00M(+62.1%)
$1.89B(+9.5%)
Sep 2017
-
$441.00M(+12.2%)
$1.72B(+1.9%)
Jun 2017
-
$393.00M(+15.9%)
$1.69B(+1.1%)
Mar 2017
-
$339.00M(-38.5%)
$1.67B(+3.7%)
Dec 2016
$1.61B(+25.8%)
$551.00M(+34.7%)
$1.61B(+3.7%)
Sep 2016
-
$409.00M(+9.1%)
$1.56B(+6.4%)
Jun 2016
-
$375.00M(+34.4%)
$1.46B(+7.7%)
Mar 2016
-
$279.00M(-43.4%)
$1.36B(+5.9%)
Dec 2015
$1.28B(-44.6%)
$493.00M(+56.0%)
$1.28B(-43.7%)
Sep 2015
-
$316.00M(+16.6%)
$2.28B(-0.2%)
Jun 2015
-
$271.00M(+33.5%)
$2.28B(-1.3%)
Mar 2015
-
$203.00M(-86.4%)
$2.31B(-0.1%)
Dec 2014
$2.32B(+49.7%)
$1.49B(+365.6%)
$2.32B(+84.5%)
Sep 2014
-
$320.00M(+6.0%)
$1.26B(-2.7%)
Jun 2014
-
$302.00M(+47.3%)
$1.29B(-7.9%)
Mar 2014
-
$205.00M(-52.2%)
$1.40B(-9.4%)
Dec 2013
$1.55B(-20.8%)
$429.00M(+20.8%)
$1.55B(-18.4%)
Sep 2013
-
$355.00M(-14.0%)
$1.90B(-3.0%)
Jun 2013
-
$413.00M(+17.7%)
$1.96B(-0.9%)
Mar 2013
-
$351.00M(-54.9%)
$1.97B(+1.0%)
Dec 2012
$1.95B(+13.4%)
$778.00M(+87.9%)
$1.95B(+9.8%)
Sep 2012
-
$414.00M(-3.9%)
$1.78B(-0.9%)
Jun 2012
-
$431.00M(+30.2%)
$1.80B(+3.8%)
Mar 2012
-
$331.00M(-45.1%)
$1.73B(+0.4%)
Dec 2011
$1.72B(+2.7%)
$603.00M(+39.9%)
$1.72B(-3.2%)
Sep 2011
-
$431.00M(+18.1%)
$1.78B(+5.5%)
Jun 2011
-
$365.00M(+12.7%)
$1.69B(+1.7%)
Mar 2011
-
$324.00M(-50.9%)
$1.66B(-1.1%)
Dec 2010
$1.68B(+14.9%)
$660.00M(+95.3%)
$1.68B(+6.5%)
Sep 2010
-
$338.00M(+0.3%)
$1.58B(+2.3%)
Jun 2010
-
$337.00M(-1.7%)
$1.54B(-1.8%)
Mar 2010
-
$343.00M(-38.5%)
$1.57B(+7.4%)
Dec 2009
$1.46B(+12.6%)
$557.40M(+83.8%)
$1.46B(+13.5%)
Sep 2009
-
$303.30M(-16.9%)
$1.29B(+1.7%)
Jun 2009
-
$365.20M(+55.3%)
$1.27B(+6.2%)
Mar 2009
-
$235.10M(-38.7%)
$1.19B(-8.2%)
Dec 2008
$1.30B(+28.4%)
$383.70M(+36.2%)
$1.30B(+8.3%)
Sep 2008
-
$281.70M(-3.3%)
$1.20B(+2.4%)
Jun 2008
-
$291.20M(-14.7%)
$1.17B(+1.6%)
Mar 2008
-
$341.40M(+19.9%)
$1.15B(+13.9%)
Dec 2007
$1.01B
$284.70M(+12.4%)
$1.01B(-1.1%)
Sep 2007
-
$253.20M(-7.0%)
$1.02B(+2.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
$272.40M(+35.7%)
$992.60M(+0.9%)
Mar 2007
-
$200.70M(-32.1%)
$983.30M(+0.3%)
Dec 2006
$980.20M(-30.1%)
$295.50M(+31.9%)
$980.20M(-10.2%)
Sep 2006
-
$224.00M(-14.9%)
$1.09B(-9.1%)
Jun 2006
-
$263.10M(+33.1%)
$1.20B(-4.5%)
Mar 2006
-
$197.60M(-51.4%)
$1.26B(-10.4%)
Dec 2005
$1.40B(-18.7%)
$406.60M(+21.8%)
$1.40B(-7.3%)
Sep 2005
-
$333.70M(+4.5%)
$1.51B(-7.0%)
Jun 2005
-
$319.20M(-7.0%)
$1.63B(-6.9%)
Mar 2005
-
$343.20M(-33.6%)
$1.75B(+1.2%)
Dec 2004
$1.73B(-9.9%)
$516.70M(+15.5%)
$1.73B(-1.4%)
Sep 2004
-
$447.30M(+1.8%)
$1.75B(-1.3%)
Jun 2004
-
$439.30M(+36.1%)
$1.77B(-2.3%)
Mar 2004
-
$322.80M(-40.4%)
$1.82B(-5.1%)
Dec 2003
$1.92B(-10.0%)
$541.80M(+15.0%)
$1.92B(-5.6%)
Sep 2003
-
$471.00M(-2.3%)
$2.03B(+6.0%)
Jun 2003
-
$482.00M(+14.5%)
$1.91B(-8.3%)
Mar 2003
-
$421.10M(-35.7%)
$2.09B(-1.9%)
Dec 2002
$2.13B(-11.4%)
$655.40M(+84.0%)
$2.13B(+13.6%)
Sep 2002
-
$356.10M(-45.6%)
$1.87B(-10.1%)
Jun 2002
-
$654.80M(+41.8%)
$2.08B(-6.6%)
Mar 2002
-
$461.80M(+15.2%)
$2.23B(-7.1%)
Dec 2001
$2.40B(-12.0%)
$400.80M(-29.2%)
$2.40B(-14.8%)
Sep 2001
-
$565.90M(-29.5%)
$2.82B(-4.9%)
Jun 2001
-
$802.30M(+26.8%)
$2.96B(+3.8%)
Mar 2001
-
$632.80M(-22.6%)
$2.86B(+4.7%)
Dec 2000
$2.73B(+6.5%)
$817.50M(+14.8%)
$2.73B(-0.1%)
Sep 2000
-
$712.30M(+2.7%)
$2.73B(+2.3%)
Jun 2000
-
$693.70M(+37.6%)
$2.67B(+3.1%)
Mar 2000
-
$504.30M(-38.6%)
$2.59B(+1.1%)
Dec 1999
$2.56B(+29.8%)
$820.90M(+26.2%)
$2.56B(+6.0%)
Sep 1999
-
$650.40M(+6.1%)
$2.42B(+5.5%)
Jun 1999
-
$613.20M(+28.8%)
$2.29B(+7.3%)
Mar 1999
-
$476.00M(-29.6%)
$2.13B(+8.1%)
Dec 1998
$1.97B(+36.2%)
$675.90M(+28.8%)
$1.97B(+12.3%)
Sep 1998
-
$524.80M(+14.8%)
$1.76B(+6.6%)
Jun 1998
-
$457.30M(+45.0%)
$1.65B(+9.7%)
Mar 1998
-
$315.40M(-31.3%)
$1.50B(+3.7%)
Dec 1997
$1.45B(+21.1%)
$459.30M(+10.5%)
$1.45B(+7.6%)
Sep 1997
-
$415.80M(+33.2%)
$1.35B(+12.8%)
Jun 1997
-
$312.10M(+19.3%)
$1.19B(+0.1%)
Mar 1997
-
$261.60M(-26.8%)
$1.19B(-0.3%)
Dec 1996
$1.20B(+19.0%)
$357.20M(+36.0%)
$1.20B(+1.4%)
Sep 1996
-
$262.60M(-15.6%)
$1.18B(-1.8%)
Jun 1996
-
$311.30M(+17.2%)
$1.20B(+8.5%)
Mar 1996
-
$265.60M(-22.1%)
$1.11B(+10.2%)
Dec 1995
$1.01B(-0.4%)
$341.10M(+19.8%)
$1.01B(+5.5%)
Sep 1995
-
$284.80M(+31.2%)
$953.50M(+2.3%)
Jun 1995
-
$217.00M(+33.5%)
$932.50M(-4.9%)
Mar 1995
-
$162.60M(-43.8%)
$981.00M(-2.8%)
Dec 1994
$1.01B(-0.3%)
$289.10M(+9.6%)
$1.01B(-3.1%)
Sep 1994
-
$263.80M(-0.6%)
$1.04B(+4.2%)
Jun 1994
-
$265.50M(+39.1%)
$1.00B(+0.1%)
Mar 1994
-
$190.90M(-40.7%)
$999.30M(-1.3%)
Dec 1993
$1.01B(-5.1%)
$321.80M(+45.0%)
$1.01B(-0.3%)
Sep 1993
-
$221.90M(-16.2%)
$1.02B(-4.7%)
Jun 1993
-
$264.70M(+29.6%)
$1.07B(-0.1%)
Mar 1993
-
$204.30M(-37.1%)
$1.07B(+0.0%)
Dec 1992
$1.07B(+2.4%)
$324.80M(+19.4%)
$1.07B(-1.8%)
Sep 1992
-
$272.10M(+2.5%)
$1.09B(+1.2%)
Jun 1992
-
$265.50M(+30.0%)
$1.07B(+2.4%)
Mar 1992
-
$204.20M(-40.6%)
$1.05B(+0.6%)
Dec 1991
$1.04B(+55.3%)
$343.90M(+32.8%)
$1.04B(+9.2%)
Sep 1991
-
$259.00M(+7.6%)
$954.10M(+9.6%)
Jun 1991
-
$240.70M(+21.6%)
$870.90M(+14.3%)
Mar 1991
-
$197.90M(-22.8%)
$762.00M(+13.6%)
Dec 1990
$670.80M(+54.9%)
$256.50M(+45.9%)
$670.80M(+61.9%)
Sep 1990
-
$175.80M(+33.4%)
$414.30M(+73.7%)
Jun 1990
-
$131.80M(+23.5%)
$238.50M(+123.5%)
Mar 1990
-
$106.70M
$106.70M
Dec 1989
$433.00M
-
-

FAQ

  • What is Merck & Co annual capital expenditures?
  • What is the all time high annual CAPEX for Merck & Co?
  • What is Merck & Co annual CAPEX year-on-year change?
  • What is Merck & Co quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Merck & Co?
  • What is Merck & Co quarterly CAPEX year-on-year change?
  • What is Merck & Co TTM capital expenditures?
  • What is the all time high TTM CAPEX for Merck & Co?
  • What is Merck & Co TTM CAPEX year-on-year change?

What is Merck & Co annual capital expenditures?

The current annual CAPEX of MRK is $3.37B

What is the all time high annual CAPEX for Merck & Co?

Merck & Co all-time high annual capital expenditures is $4.45B

What is Merck & Co annual CAPEX year-on-year change?

Over the past year, MRK annual capital expenditures has changed by -$491.00M (-12.71%)

What is Merck & Co quarterly capital expenditures?

The current quarterly CAPEX of MRK is $937.00M

What is the all time high quarterly CAPEX for Merck & Co?

Merck & Co all-time high quarterly capital expenditures is $1.49B

What is Merck & Co quarterly CAPEX year-on-year change?

Over the past year, MRK quarterly capital expenditures has changed by $0.00 (0.00%)

What is Merck & Co TTM capital expenditures?

The current TTM CAPEX of MRK is $3.37B

What is the all time high TTM CAPEX for Merck & Co?

Merck & Co all-time high TTM capital expenditures is $4.94B

What is Merck & Co TTM CAPEX year-on-year change?

Over the past year, MRK TTM capital expenditures has changed by $0.00 (0.00%)
On this page